Flumazenil
- Level
- Commodity
- Parent
- 51401500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401525This classification denotes a neuroprotective agent with the molecular formula C15H14FN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 40P7XK9392, chemically known as 4h-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylic acid, 8-fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester but generally known as flumazenil, which bears US NIH Compound Identifier 3373. European Medicines Agency schedules Flumazenil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07693MIG. The term FLUMAZENIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). World Health Organization schedules flumazenil in its Anatomical Therapeutic Chemical (ATC) Classification. FLUMAZENIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flumazenil under HS 29339940 and SITC 51577. As of Q4 2014, FLUMAZENIL remains the US FDA Preferred Term for this commodity. Flumazenil bears US NLM identifiers UMLS ID C0016293 and NCI Concept Code C47534. SMILES: FC1CC2C(N3C(CN(C2=O)C)C(NC3)C(=O)OCC)CC1.
Same parent
Under 51401500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.